Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUP1602-C in Non-healing Neuro-ischemic Diabetic Foot Ulcers
NCT06111183Phase 2Completed
- Sponsor
- Aurealis Therapeutics
- Start
- Jul 2023
- Primary completion
- Nov 2025
- Countries
- 3
01
Overview
A Phase 2 trial of AUP-16 in diabetic foot ulcer (DFU), sponsored by Aurealis Therapeutics. Started Jul 2023; status: completed.
02
Drugs
AUP-16
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT06111183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06111183.